
Extended Half-Life (EHL) Factor Therapy
This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options
Year: 2012
Language: English
This resource is also available in: Spanish
Author(s): Paul Giangrande
Format: Document
Acquired hemophilia is a rare condition caused by the production of autoantibodies, which inactivate factor VIII. This paper provides an overview of this condition that affects both men and women, its clinical features, epidemiology, laboratory diagnosis, and management.

This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options

This video gives a quick introduction to bispecific antibody therapy. Learn more about different treatment options for hemophilia with the

This video gives a quick introduction to standard half-life (SHL) clotting factor replacement therapy. Learn more about different treatment options

This fact sheet contains commonly asked questions and more information on standard half-life (SHL) and extended half-life (EHL) clotting factor

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

Psychosocial support is an important part of comprehensive care for people with hemophilia. The aim of this monograph is to